[S11] Frontiers of mid-size drug discovery research —chemical approach that accelerates mid-size drug discovery—

3:45 PM - 4:05 PM JST(6:45 AM - 7:05 AM UTC)

[S11-3] Design of anti-miR21 oligonucleotide composed of acyclic nucleic acid

○Yukiko Kamiya^1,2,3 (1. Lab. of Bioanal. Chem., Kobe Pharmaceutical Univ., 2. Grad. Sch. of Eng., Nagoya Univ., 3. Inst. for Mol. Sci.)